Moderna
MRNA
#276
Rank
C$119.49 B
Marketcap
C$295.32
Share price
3.43%
Change (1 day)
769.75%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -C$4.25 Billion

According to Moderna 's latest financial reports the company's current earnings are C$2.21 Billion. In 2025 the company made an earning of -C$3.96 Billion, an increase over its 2024 earnings that were of -C$5.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$4.25 Billion7.33%
2025 -C$3.96 Billion-23.03%
2024 -C$5.14 Billion-8.22%
2023 -C$5.6 Billion-140.65%
2022 C$13.75 B-27.81%
2021 C$19.05 B-1911.15%
2020 -C$1.06 Billion44.7%
2019 -C$0.73 Billion28.63%
2018 -C$0.57 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.81 B-714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$18.10 B-515.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$9.63 B-320.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-C$67.94 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$59.83 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.74 B-140.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-C$0.23 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA